Coverage
-
April 08, 2019
Bio-Rad Laboratories Inc.'s technology to reduce sample contamination and loss is patent-eligible, a Delaware federal judge said Monday in allowing the company to press forward with an infringement suit against 10X Genomics Inc.
1 other articles on this case.
View all »